Literature DB >> 14580960

Specific chemotherapy of Chagas disease: controversies and advances.

Julio A Urbina1, Roberto Docampo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14580960     DOI： 10.1016/j.pt.2003.09.001

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


× No keyword cloud information.
  142 in total

1.  Role of CCL3/MIP-1alpha and CCL5/RANTES during acute Trypanosoma cruzi infection in rats.

Authors:  Ester Roffê; Fabiano Oliveira; Adriano L S Souza; Vanessa Pinho; Danielle G Souza; Patrícia R S Souza; Remo C Russo; Helton C Santiago; Alvaro J Romanha; Herbert B Tanowitz; Jesus G Valenzuela; Mauro M Teixeira
Journal:  Microbes Infect       Date:  2010-05-07       Impact factor: 2.700

Review 2.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

3.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

4.  Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro.

Authors:  Daniel Adesse; Eduardo Meirelles Azzam; Maria de Nazareth L Meirelles; Julio A Urbina; Luciana R Garzoni
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

5.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.

Authors:  Milagros Corrales; Rubén Cardozo; María Asunción Segura; Julio A Urbina; Miguel Angel Basombrío
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.

Authors:  Marcela L Ferraz; Ricardo T Gazzinelli; Rosana O Alves; Julio A Urbina; Alvaro J Romanha
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

8.  Preparation, crystallization and preliminary crystallographic analysis of old yellow enzyme from Trypanosoma cruzi.

Authors:  Shigeru Sugiyama; Keiji Tokuoka; Nahoko Uchiyama; Naoki Okamoto; Yousuke Okano; Hiroyoshi Matsumura; Koji Inaka; Yoshihiro Urade; Tsuyoshi Inoue
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-29

9.  Structurally simple inhibitors of lanosterol 14alpha-demethylase are efficacious in a rodent model of acute Chagas disease.

Authors:  Praveen Kumar Suryadevara; Srinivas Olepu; Jeffrey W Lockman; Junko Ohkanda; Mandana Karimi; Christophe L M J Verlinde; James M Kraus; Jan Schoepe; Wesley C Van Voorhis; Andrew D Hamilton; Frederick S Buckner; Michael H Gelb
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

10.  Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.

Authors:  Pablo D Elicio; María N Chao; Melina Galizzi; Catherine Li; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  Eur J Med Chem       Date:  2013-09-18       Impact factor: 6.514
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.